Dyne Therapeutics Ownership | Who Owns Dyne Therapeutics?
Dyne Therapeutics Ownership Summary
Dyne Therapeutics is owned by 112.89% institutional investors, 0.49% insiders. Blackrock is the largest institutional shareholder, holding 9.11% of DYN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.74% of its assets in Dyne Therapeutics shares.
DYN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Dyne Therapeutics | 112.89% | 0.49% | -13.38% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 7.39M | 9.11% | $260.69M |
| Ra capital management | 9.71M | 8.53% | $92.48M |
| Atlas venture life science advisors | 9.13M | 8.02% | $86.92M |
| Fmr | 8.00M | 7.93% | $188.41M |
| Janus henderson group | 7.38M | 7.31% | $173.81M |
| Blackrock funding, inc. /de | 8.08M | 7.09% | $76.91M |
| Vanguard group | 6.70M | 6.65% | $157.94M |
| Fcpm iii services b.v. | 5.46M | 4.80% | $52.01M |
| Siren | 4.84M | 4.25% | $46.04M |
| State street | 3.72M | 3.68% | $87.58M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Mpm asset management | 682.38K | 14.99% | $6.50M |
| Fcpm iii services b.v. | 5.46M | 14.09% | $52.01M |
| Atlas venture life science advisors | 9.13M | 13.12% | $86.92M |
| Saturn v capital management | 1.46M | 5.62% | $13.86M |
| Tcg crossover management | 3.77M | 4.10% | $35.86M |
| Bioimpact capital | 1.45M | 2.39% | $13.77M |
| Siren | 4.84M | 2.38% | $46.04M |
| Logos global management lp | 1.90M | 2.00% | $18.09M |
| Ra capital management | 9.71M | 1.56% | $92.48M |
| Vr adviser | 2.17M | 1.55% | $20.70M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Adage capital partners gp | 3.19M | 0.05% | 3.19M |
| Siren | 4.84M | 2.38% | 2.12M |
| Blackrock | 7.39M | 0.01% | 2.00M |
| Saturn v capital management | 1.46M | 5.62% | 1.46M |
| Bioimpact capital | 1.45M | 2.39% | 1.45M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Holocene advisors, lp | - | - | -2.35M |
| Deep track capital, lp | - | - | -2.00M |
| Jefferies financial group | - | - | -1.80M |
| Point72 asset management | 123.28K | 0.00% | -1.41M |
| Jennison associates | - | - | -1.21M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Saturn v capital management | 1.46M | 5.62% | 1.46M | $13.86M |
| Bioimpact capital | 1.45M | 2.39% | 1.45M | $13.77M |
| Norges bank | 950.10K | 0.00% | 950.10K | $22.38M |
| Bnp paribas arbitrage, snc | 67.00K | 0.00% | 67.00K | $1.58M |
| Troluce capital advisors | 50.00K | 0.17% | 50.00K | $1.76M |
Sold Out
| Holder | Change |
|---|---|
| Headlands | -1.00 |
| Farther finance advisors | -3.00 |
| Ifp advisors | -3.00 |
| Nelson, van denburg & campbell wealth management group | -9.00 |
| J.safra asset management | -11.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 198 | -5.71% | 128,546,973 | 5.45% | 112 | 0.92% | 116 | -10.08% | 52 | 15.56% |
| Mar 31, 2025 | 25 | -87.86% | 30,059,507 | -73.06% | 27 | 0.22% | 15 | -85.98% | 6 | -90.32% |
| Dec 31, 2024 | 204 | -1.45% | 111,580,268 | -0.38% | 110 | 0.90% | 105 | -10.26% | 62 | 14.81% |
| Sep 30, 2024 | 207 | 5.08% | 111,994,758 | 0.90% | 111 | 0.59% | 117 | -7.14% | 54 | 17.39% |
| Jun 30, 2024 | 197 | 12.57% | 110,993,406 | 16.43% | 136 | 0.99% | 126 | -1.56% | 46 | 58.62% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 3.90M | 2.74% | 827.02K |
| Vanguard US Total Market Shares ETF | 2.65M | 2.35% | 2.40K |
| Fidelity Growth Compy Commingled Pl O | 1.79M | 1.78% | 348.61K |
| Janus Henderson Glb Life Scn I2 USD | 2.40M | 1.69% | 844.64K |
| iShares Russell 2000 ETF | 2.19M | 1.54% | -41.69K |
| Janus Henderson Global Life Sciences D | 1.89M | 1.33% | 80.26K |
| Janus Henderson Global Life Sciences | 1.89M | 1.33% | 124.72K |
| Fidelity Growth Compy Commingled Pl S | 1.84M | 1.29% | -831.00 |
| T. Rowe Price New Horizons | 1.12M | 1.10% | -5.57K |
| US Small-Cap Growth II Equity Comp | 1.12M | 1.10% | 219.42K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 05, 2025 | Cox John | CEO & President | Sell | $35.40K |
| Sep 05, 2025 | Friedl-Naderer Johanna | Chief Commercial Officer | Sell | $1.93K |
| Sep 04, 2025 | Friedl-Naderer Johanna | Chief Commercial Officer | Sell | $11.86K |
| Sep 04, 2025 | Kerr Douglas | Chief Medical Officer | Sell | $47.14K |
| Sep 05, 2025 | Kerr Douglas | Chief Medical Officer | Sell | $11.71K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | 1 | - |
| 2025 Q2 | - | 3 |
| 2025 Q1 | - | 9 |
| 2024 Q4 | - | 24 |
| 2024 Q3 | 2 | 79 |
DYN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools